preloader

Email Us

info@prorelixresearch.com

Single Blog

India- Great Destination for Clinical Research

India- Great Destination for Clinical Research

India has always been a hot destination to conduct clinical trials. Many key factors of doing clinical research in India, make it a worthy place.

It’s very logical for sponsors who are interested in selling their products to India’s 1.25 billion population, where demand for new medicines is increasing considerably. Approximately 17% of the world’s population and 20% of the global disease burden is in India.

There is an opportunity to recruit from a huge patient pool who may be eager to participate in trials that would give them access to life-saving drugs. Availability of infrastructure and skilled young manpower, English speaking and trained talent pool to manage clinical trials, and all this at a lower cost. In recent times the licensing authority of India (CDSCO) has taken steps to fast track approvals for clinical trials and has also given more freedom and responsibilities to Ethics Committees.

These key factors to conduct clinical trials in India give sponsors an opportunity of competitive advantage of cost-effective trials with access to a huge patient population, expertize, and ready infrastructure.

Contract Research Organization or Clinical Research Organization (CRO) in India 

Introduction:

The clinical trial industry is continuously undergoing positive growth in India. At ProRelix Research we are a goal-driven niche Global CRO, passionate about delivering clinical study solutions to meet your needs. At every step, we provide expert professional support in order to meet your clinical trial objectives. We recognize that you need experienced, highly motivated, flexible specialists who are able to perform all tasks no matter how big or small. We have the operational flexibility to provide drug development services on a stand-alone basis or as part of an integrated full-service solution.

Various services that are being offered for global clients:

– Clinical operations

– Clinical data management & Stat Analysis

– Medical writing

– Pharmacovigilance

The therapeutic expertize includes:

– Oncology

– Ophthalmology

– Cardiovascular Disease

– Central Nervous System

– Endocrinology

– Respiratory Diseases

– Infectious Diseases

By:

Mr. Niranjan Andhalkar

Director- Business Development & Client Relations

ProRelix Research

Niranjan Andhalkar

https://prorelixresearch.com/mr-niranjan-andhalkar/

( Director – Strategic Management & Planning ) - Mr. Niranjan Andhalkar is a visionary leader with more than 17 years of proven expertise in clinical research, strategic management, and business innovation. Recognized for his ability to blend entrepreneurial spirit with strategic foresight, he has successfully built, scaled, and transformed businesses across Contract Research Organizations (CROs), pharmaceuticals, healthcare IT. His dynamic leadership style and relentless pursuit of excellence have positioned him as a trusted figure in the international clinical research ecosystem. A seasoned strategist, Mr. Andhalkar is celebrated for his work to drive growth, enhance operational efficiency, and create sustainable value in highly competitive markets. He has an exceptional track record of fostering strategic alliances, steering multinational collaborations, and spearheading business innovations that have consistently set new benchmarks in the industry. His influence extends beyond corporate leadership, as he also contributes to the advancement of science and innovation through advisory and editorial roles in reputed international journals. Passionate about shaping the future of healthcare, Mr. Andhalkar is deeply committed to creating organizations that not only achieve financial success but also set new standards of quality, integrity, and impact in the industry. His leadership continues to inspire teams, empower clients, and redefine benchmarks across the global clinical research ecosystem. Mr. Andhalkar holds advanced academic credentials in both Life Sciences and Management. He earned his graduation in Biotechnology, followed by a postgraduate degree in Clinical Research, equipping him with deep scientific expertise. To complement his technical foundation, he pursued an MBA in Operations Management, which has enabled him to successfully integrate scientific rigor with business strategy—driving innovation, operational excellence, and long-term sustainability across his ventures.

Subscribe to our Newsletter

Be the first to know the latest trends in clinical research, real-world case studies, and industry secrets.

[fluentform id="3"]
prorelix research

ProRelix Research is the rapidly growing Contract/ Clinical Research Organization (CRO) with multi-country service capability supporting phase 1, 2, 3, & 4 clinical trials of Pharma, Biotech, Biopharma, Medical Device, Nutraceutical & Herbal companies to conduct in the USA, India, Europe & South East Asia.